Reprint
Bacterial Meningitis
Epidemiology and Vaccination
Edited by
August 2021
274 pages
- ISBN978-3-0365-1807-7 (Hardback)
- ISBN978-3-0365-1808-4 (PDF)
This is a Reprint of the Special Issue Bacterial Meningitis: Epidemiology and Vaccination that was published in
Biology & Life Sciences
Environmental & Earth Sciences
Medicine & Pharmacology
Summary
This timely collection of expert papers draws attention to the global burden of meningitis and the challenges faced by the WHO’s roadmap to defeat meningitis by 2030. The three main goals of the meningitis roadmap are to eliminate epidemics of bacterial meningitis, reduce cases and deaths from vaccine-preventable bacterial meningitis, and reduce disability and improve quality of life after meningitis of any cause. This book includes a wide range of original research and reviews on epidemiology and vaccination of bacterial meningitis that have direct relevance to advancing the goals of the roadmap.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
meningitis; child mortality; neonatal sepsis; global health; global health estimates; modelling; Streptococcus pneumoniae; Haemophilus influenzae; Neisseria meningitidis; bacterial meningitis; S. pneumoniae; N. meningitidis; H. influenzae; S. agalactiae; conjugate vaccines; post-vaccine surveillance; meningitis; vaccine; Africa; mathematical modelling; susceptibility; invasive bacterial infections; complement; genetic factors; Neisseria meningitidis; Streptococcus pneumoniae; Haemophilus influenzae; Streptococcus agalactiae; group B streptococci; Neisseria meningitidis; capsule; meningococcal group; nongroupable; meningococcal carriage; invasive meningococcal disease; meningococcal urethritis; neonatal infections; meningitis; epidemiology; antibiotic resistance; etiologic diagnosis; enterovirus; group B Streptococcus; bacterial meningitis; neurological sequelae; hearing loss; seizure; epilepsy; hydrocephalus; focal neurological deficit; vaccine; corticosteroid; dexamethasone; invasive pneumococcal disease; pneumococcal conjugate vaccines; serotypes; vaccine impact; pneumococcal meningitis; serotype distribution; PCV impact; global; meta-analysis; global; invasive pneumococcal disease; pneumococcal meningitis; surveillance; pneumococcal conjugate vaccines; meningitis; meningococcus; pneumococcus; Haemophilus influenzae; Hib; group B streptococcus; conjugate vaccine; meningitis; Neisseria meningitidis; Streptococcus pneumoniae; rapid diagnostic test; national reference laboratory; cerebrospinal fluid; Niger; Burkina Faso; tuberculosis; tuberculous meningitis; TBM; children; Haemophilus influenzae; Hib; impact of Hib conjugate vaccine; Hia; NTHi; meningitis; burden; social and economic costs; neurological sequelae; WHO meningitis roadmap; tuberculous meningitis; disability; n/a